Among them, one meta-analysis that includes 13 studies with 3038 patients and another meta-analysis that includes 14 studies with 3322 patients reported an overall incidence of the U2AF1 mutant of 11.7% in MDS patients [32,33]. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.